139 related articles for article (PubMed ID: 16925132)
1. The cytokines and the B-cell malignancies: a new spin on maximizing therapeutic outcomes.
Snively AH
ONS News; 2006; 21(8 Suppl):13-4. PubMed ID: 16925132
[No Abstract] [Full Text] [Related]
2. NCCN: Non-Hodgkin's lymphoma.
Zelenetz AD; Hoppe RT;
Cancer Control; 2001; 8(6 Suppl 2):102-13. PubMed ID: 11760551
[No Abstract] [Full Text] [Related]
3. NCCN preliminary non-Hodgkin's lymphoma practice guidelines.
Oncology (Williston Park); 1997 Nov; 11(11A):281-46. PubMed ID: 9430195
[No Abstract] [Full Text] [Related]
4. [Hematology 2010].
Dreyling M; Subklewe M; Braess J; Spiekermann K
Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
[No Abstract] [Full Text] [Related]
5. Non-Hodgkin's lymphomas: understanding monoclonal antibody therapy.
Hendrix C
ONS News; 2006; 21(8 Suppl):19-20. PubMed ID: 16925135
[No Abstract] [Full Text] [Related]
6. Primary cutaneous B-cell lymphoma: subtypes, treatment and outcome of 10 cases.
Onsun N; Su O; Kural YB; Erdemoglu Y; Buyukbabani N; Demirkesen C; Aydin Y
Acta Derm Venereol; 2011 Jun; 91(4):476-8. PubMed ID: 21537819
[No Abstract] [Full Text] [Related]
7. The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma.
Dunleavy K; Staudt LM; Wilson WH
Leuk Lymphoma; 2007 Jun; 48(6):1061-3. PubMed ID: 17577765
[No Abstract] [Full Text] [Related]
8. The differential diagnosis between primary cutaneous large B-cell lymphoma and cutaneous follicular lymphoma: prognostic and therapeutic implications.
Fernandez-Flores A; Smucler-Simonovich A; Escalante F; Manjon JA
Am J Dermatopathol; 2011 Dec; 33(8):819-26. PubMed ID: 22042259
[TBL] [Abstract][Full Text] [Related]
9. A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.
Koç ON; Redfern C; Wiernik PH; Rosenfelt F; Winter JN; Carter WD; Gold DP; Stewart ME; Ghalie RG; Bender JF
J Immunother; 2010; 33(2):178-84. PubMed ID: 20145546
[TBL] [Abstract][Full Text] [Related]
10. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
Imamura T; Yoshihara T; Morimoto A; Ishida H; Sugimoto T; Imashuku S
Pediatr Hematol Oncol; 2006; 23(1):19-24. PubMed ID: 16326408
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
12. [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma].
Mao ZR; Zhou R; Zhang XX; Mueller-Hermelink Hk; Rosenwald A
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):785-9. PubMed ID: 20079025
[No Abstract] [Full Text] [Related]
13. Monoclonal antibodies in lymphoma: the first decade.
Link BK; Friedberg JW
Semin Hematol; 2008 Apr; 45(2):71-4. PubMed ID: 18381100
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody therapies for follicular non-Hodgkin's lymphomas: moving toward a cure.
McGee L
ONS Connect; 2007; 22(8 Suppl):39-40. PubMed ID: 17824558
[No Abstract] [Full Text] [Related]
16. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.
Niitsu N; Hayama M; Okamoto M; Khori M; Higashihara M; Tamaru J; Hirano M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4077-82. PubMed ID: 15217942
[TBL] [Abstract][Full Text] [Related]
18. Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia.
Lamanna N; Weiss MA
Curr Oncol Rep; 2008 Sep; 10(5):363-4. PubMed ID: 18706262
[No Abstract] [Full Text] [Related]
19. Monoclonal antibody to treat lymphoma.
Marwick C
JAMA; 1997 Aug; 278(8):616, 618. PubMed ID: 9272879
[No Abstract] [Full Text] [Related]
20. Transformed follicular non-Hodgkin lymphoma.
Casulo C; Burack WR; Friedberg JW
Blood; 2015 Jan; 125(1):40-7. PubMed ID: 25499449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]